Arbutus Biopharma Corporation

ABUS ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Returns on Capital

ROE ROI ROA

Fiscal Year	ROE	ROI	ROA
FY2024	-71.8%	-71.8%	-53.1%
FY2025	-43.7%	-43.7%	-35.4%